Zobrazeno 1 - 10
of 370
pro vyhledávání: '"A. N. BOYKO"'
Autor:
A. N. Boyko, V. M. Alifirova, D. V. Pashkovskaya, E. I. Kuchina, S. A. Sivertseva, E. L. Turova, Z. A. Goncharova, O. Yu. Rudenko, Yu. Yu. Pogrebnova, F. A. Khabirov, T. I. Khaibullin, N. N. Babicheva, N. L. Khoroshilova, O. V. Dzundza, O. A. Soldatova, A. N. Belova, G. Е. Sheiko, A. Е. Makarova, N. G. Glavinskaya
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 16, Iss 0, Pp 44-50 (2024)
Multiple sclerosis (MS) is an autoimmune-inflammatory and neurodegenerative disease of the central nervous system. The article analyses the ability of cladribine, which due to its selective lymphotoxic effect on activated cells and central effect on
Externí odkaz:
https://doaj.org/article/13341d6d8452436192ed66135a401fd3
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 16, Iss 0, Pp 31-37 (2024)
Objective: to look for differences in the transcriptome profiles in mononuclear blood cells of a group of patients with radiologically isolated syndrome (RIS) who developed symptoms of multiple sclerosis (MS) in the following three years of observati
Externí odkaz:
https://doaj.org/article/6bdaa64ad8d5454b8e560ec2c05dfa07
Autor:
S. A. Sivertseva, K. S. Anfilofeva, A. V. Zotova, V. D. Chukreev, A. Yu. Belkina, L. I. Volkova, M. E. Guseva, A. N. Boyko
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 16, Iss 0, Pp 18-24 (2024)
Multiple sclerosis (MS) is a chronic autoimmune disease of the nervous system of a predominantly progressive nature. In addition to diseasemodifying drug therapy of MS patients require physical rehabilitation, including tele-rehabilitation (TeleRBT).
Externí odkaz:
https://doaj.org/article/4ef33963855e40a2929516f0f8aa3bbe
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 16, Iss 0, Pp 4-10 (2024)
Search for agents for the add-on therapy of multiple sclerosis (MS) that can enhance the effect of first-line MS disease-modifying therapy (DMTs) is a very current issue. Such a boost is needed to reduce the need to switch to second-line DMTs, whose
Externí odkaz:
https://doaj.org/article/dd91818ecb6240a0adc581fd4e436edc
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 16, Iss 0, Pp 88-90 (2024)
The article provides an analysis of modern methods of treatment of secondary progressive multiple sclerosis (SPMS). The only drug that has proven its effectiveness in all types of SPMS (with exacerbations and without exacerbations) is siponimod. Clin
Externí odkaz:
https://doaj.org/article/801c56066d954331893c62e836625fab
Autor:
A. N. Boyko, V. V. Vashchilin, O. V. Boyko, A. G. Bunyak, D. S. Kasatkin, D. S. Korobko, S. I. Kulikova, N. V. Mazgo, N. V. Makovskaya, S. A. Sivertseva, I. V. Smagina, T. N. Chernukha
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 15, Iss 6, Pp 146-150 (2023)
A joint conclusion of the Russian-Belarusian Expert Council “New opportunities in the treatment of patients with multiple sclerosis” on the organization of medical care, diagnosis and treatment of multiple sclerosis (MS) and other autoimmune dise
Externí odkaz:
https://doaj.org/article/22582051b1314be580478f4ed0d19f70
Autor:
M. A. Omarova, A. N. Boyko
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 15, Iss 6, Pp 122-127 (2023)
An increase in the incidence of multiple sclerosis (MS) has been reported over the last decade, possibly due to environmental factors. The purpose of this review article is to summarize current advances in the understanding of the gut-brain axis, whi
Externí odkaz:
https://doaj.org/article/a864d5dcc5d94fb1a5bf220cfba50c75
Autor:
S. A. Ryabov, A. N. Boyko
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 15, Iss 0, Pp 26-30 (2023)
Objective: to identify characteristic gait parameters by video analysis in patients with multiple sclerosis (MS) that allow the most reliable discrimination of the dominant profile in functional systems.Material and methods. We examined 45 patients (
Externí odkaz:
https://doaj.org/article/28c9ca023cee41b9baa01f3fbbb9154a
Autor:
P. A. Zaitseva, A. N. Boyko
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 15, Iss 0, Pp 49-57 (2023)
In the review, we present the main pathogenetic mechanisms of the development of neuromyelitis optic spectrum disorders (NMOSD) associated with the appearance of anti-aquaporin-4 (APQ4-IgG) autoantibodies: damage to astrocytes, including complement-d
Externí odkaz:
https://doaj.org/article/29075cb166714f579a4fc27c42fe3578
Autor:
T. O. Simaniv, K. Z. Bakhtiyarova, A. N. Belova, Z. A. Goncharova, S. A. Sivertseva, N. N. Spirin, N. A. Totolyan, T. N. Trushnikova, E. L. Turova, T. I. Khaibullin, M. A. Sherman, A. N. Boyko
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 15, Iss 0, Pp 71-75 (2023)
Neuromyelitis optic spectrum disorders (NMOSD) are rare, severely disabling diseases of the central nervous system. They are characterized by periodic, unpredictable exacerbations that lead to an accumulation of irreversible neurologic damage. Despit
Externí odkaz:
https://doaj.org/article/298d9945790f4c46830ed8b7004d3aa3